Citigroup
OMIC

Citigroup’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Citigroup’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$15 – 5833
2024
Q1 		$15 Hold
1
– – ﹤0.01% 5553
2023
Q4 		$13 Hold
1
– – ﹤0.01% 5628
2023
Q3 		$11 Sell
1
-3
-75% -$56 ﹤0.01% 5610
2023
Q2 		$107 Buy
+4
New +$117 ﹤0.01% 5453
2023
Q1 		– Sell
-43
Closed -$2.56K – 5955
2022
Q4 		$2.56K Sell
43
-14
-25% -$938 ﹤0.01% 5170
2022
Q3 		$4K Sell
57
-112
-66% -$11.7K ﹤0.01% 5340
2022
Q2 		$19K Sell
169
-741
-81% -$86.9K ﹤0.01% 5048
2022
Q1 		$172K Sell
910
-224
-20% -$51.8K ﹤0.01% 4156
2021
Q4 		$393K Buy
1,134
+1,089
+2,420% +$422K ﹤0.01% 3951
2021
Q3 		$15K Buy
+45
New +$23.1K ﹤0.01% 5364

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Citigroup's OMIC Position: Q2 2024 in Review

Citigroup sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2024, closing a stake of 1 share — an estimated $15 sold.

Citigroup first reported a position in OMIC in Q3 2021 and held it in 10 quarters. The position peaked at $393K in Q4 2021. 24 funds tracked by Wall St. Rank hold OMIC as of Q2 2024.

  • Citigroup reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Citigroup sold 1 Singular Genomics Systems, Inc. Common Stock share in Q2 2024, an estimated $15.
  • Citigroup first reported a position in Singular Genomics Systems, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Citigroup's Singular Genomics Systems, Inc. Common Stock position peaked at $393K in Q4 2021.
  • 24 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2024.

Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.